Seroprotection against measles in previously vaccinated children with difficult-to-treat nephrotic syndrome
- PMID: 34564736
- DOI: 10.1007/s00467-021-05290-7
Seroprotection against measles in previously vaccinated children with difficult-to-treat nephrotic syndrome
Abstract
Background: Children with nephrotic syndrome (NS) are vulnerable to infections. Measles infection is an important cause of morbidity and mortality in immunosuppressed children. A suboptimal seroprotection against measles has been shown in immunocompromised children. There is limited published literature on measles immunity in children with difficult-to-treat nephrotic syndrome (DTNS). We compared the proportions of children with DTNS and healthy controls who were seroprotected against measles.
Methods: This was a cross-sectional study. Measles-specific IgG antibodies of 108 children with DTNS (3 to 10 years of age) and an equal number of age-matched healthy controls were measured. All children had received two doses of measles-containing vaccine at 9-12 and 16-24 months of age under routine immunisation programme. Serum measles IgG antibody titres were measured by indirect ELISA. The assay results were interpreted as (1) > 11 NTU (NovaTec Units), positive/seroprotective titres; (2) 9-11, equivocal; and (3) < 9 NTU, negative. Inter- and intra-group comparisons were made to identify the disease characteristics related to seroprotection status.
Results: The proportion of children with protective anti-measles antibodies (n = 70, 65%) was significantly lower in DTNS as compared to controls (n = 88, 81.48%) (p = 0.005). Their median [IQR] antibody titres were also significantly lower than those in controls (14.1 [14] NTU vs. 18.3 [15.2] NTU (p = 0.001). The age, gender, clinical subtype, duration of disease, and type of immunosuppressive therapy were not significantly different between seroprotected and non-seroprotected children with DTNS.
Conclusion: A significantly lower percentage of fully vaccinated children with DTNS were seroprotected against measles compared to healthy controls. A higher resolution version of the Graphical abstract is available as Supplementary information.
Keywords: Measles; Seroprotection; Steroid-resistant nephrotic syndrome; Steroid-sensitive nephrotic syndrome.
© 2021. The Author(s), under exclusive licence to IPNA.
References
-
- Mishra OP, Abhinay A, Mishra RN, Prasad R, Pohl M (2013) Can we predict relapses in children with idiopathic steroid-sensitive nephrotic syndrome? J Trop Pediatr 59:343–349 - DOI
-
- Alwadhi RK, Mathew JL, Rath B (2004) Clinical profile of children with nephrotic syndrome not on glucorticoid therapy, but presenting with infection. J Paediatr Child Health 40:28–32 - DOI
-
- Alfakeekh K, Azar M, Sowailmi BA, Alsulaiman S, Makdob SA, Omair A et al (2019) Immunosuppressive burden and risk factors of infection in primary childhood nephrotic syndrome. J Infect Public Health 12:90–94 - DOI
-
- Gulati S, Kher V, Gupta A, Arora P, Rai PK, Sharma RK (1995) Spectrum of infections in Indian children with nephrotic syndrome. Pediatr Nephrol 9:431–434 - DOI
-
- Patel MK, Goodson JL, Alexander JP Jr et al (2020) Progress toward regional measles elimination – Worldwide, 2000–2019. MMWR Morb Mortal Wkly Rep 69:1700–1705 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous